Second Amended and Restated License, Product Development and Supply Umbrella AgreementLicense, Product Development and Supply Umbrella Agreement • October 15th, 2019 • TELA Bio, Inc. • Surgical & medical instruments & apparatus • Delaware
This Second Amended and Restated License, Product Development and Supply Umbrella Agreement (this “Umbrella Agreement”) is made as of the 16th day of July, 2015 (the “Effective Date”) by and between TELA Bio, Inc., a Delaware corporation (“TELA Bio”), and Aroa Biosurgery Ltd. (previously Mesynthes Ltd.), a privately held New Zealand company (“Aroa”), and amends and restated in its entirety that certain License, Product Development and Supply Umbrella Agreement dated as of August 3, 2012 (the “Original Agreement”) by and between TELA Bio and Aroa as amended and restated by that certain Amended and Restated License, Product Development and Supply Umbrella Agreement dated March 12, 2013 by and between TELA Bio and Aroa (the “First Amendment”).
